2025 is off to a rough start for stocks, but there are still some pockets of strength in the market. Year-to-date, SPY is…
Category:
Editor’s Pick
-
-
One thing to understand about sentiment measures is that they are contrarian. If investors are too bullish or too bearish, everyone has jumped…
-
Stephen Slivinski and Yasmeen Kallash-Kyler Housing policy reform is tricky. Getting policy changes off the ground in the first place can be difficult…
-
Editor's PickInvesting
Trump’s Tariff Walkback Bows to Economic Reality but Leaves Plenty of Problems
Alfredo Carrillo Obregon and Scott Lincicome On March 6, President Donald Trump exempted Canadian and Mexican imports that enter the US free of duty…
-
Editor's PickInvesting
The FDA Finally Removes a Huge Barrier to an Effective Schizophrenia Medicine
Jeffrey A. Singer As Josh Bloom and I wrote last November, the Food and Drug Administration (FDA) imposed onerous requirements on health care…
-
Colleen Hroncich Remote pandemic schooling wasn’t working for her second-grade daughter, so Rebecca Simmons decided it was a good time to start homeschooling.…
-
Jeffrey Miron and Jacob Winter Much debate exists about whether the US tax and transfer system unfairly benefits wealthy people at the expense…
-
Editor's PickInvesting
Evaluating PDUFA: Paying for FDA Drug-Application Reviewers by Charging User Fees
Michael F. Cannon A congressional staffer recently asked about the performance of the Food and Drug Administration (FDA), including the Prescription Drug User…
-
And, the Oscar, er, top StockCharts Technical Rank (SCTR) goes to XPeng, Inc. (XPEV), a Chinese smart electric vehicle (EV) manufacturer. XPEV has…
-
If the essence of stock investing is to buy low and sell high, then buying not just low, but at a steep discount,…